President-elect Donald Trump's second term promises profound shifts across commerce, technology, and regulation that will reshape how businesses operate and consumers behave. As the president-elect prepares to take office, his policy priorities are already triggering market reactions and pivots from major corporations.

The law enforcement agency is seeking civil penalties against the neobank, replacing the FTC’s original lawsuit.

A big Google decision is coming in 2025: A judge will rule in April on several DOJ proposals that Google sell Chrome and syndicate its data.

The FTC’s case against Southern Glazer’s could have profound implications for large retailers like Walmart and Costco: A successful suit could limit their ability to negotiate lower prices with suppliers, narrowing their advantage over smaller retailers.

FTC warns ACA marketplace insurance marketers about deceptive claims: The warnings come during open enrollment season, a period that typically creates confusion among consumers.

The FTC’s new leader could follow through on advertising regulation: Andrew Ferguson has voiced support for targeted ads, but criticized data collection.

The free, ad-supported internet runs on consumer data. But privacy legislation is making it harder for advertisers to take advantage of it.

Claiming anticompetitive behavior, Google asks the FTC to break up the exclusive partnership, arguing that it locks rivals out and entrenches Azure’s dominance.

Albertsons blames Kroger for blocked merger: The grocer is seeking billions in damages, claiming the latter failed to make necessary concessions to appease regulators.

FTC scores another antitrust victory after judge blocks Kroger-Albertsons merger: The deal would reduce grocery competition and raise prices for shoppers, the court decided.

Dr. Oz could be investigated for violating FTC influencer marketing guidelines: A consumer advocacy group triggered the investigation. We examine the complaints and explore what this scrutiny means for healthcare influencers.

A decision against SiriusXM’s cancellation process underlines the brand risks of burdensome subscription practices as the FTC tightens consumer protections.

Big 3 pharmacy benefit managers countersue FTC: They allege the FTC's case against them over insulin prices is unconstitutional. While it might be a savvy legal tactic, it shouldn’t divert attention from PBMs’ role in rising prescription drug costs.

Regulatory rollbacks could ignite a wave of acquisitions, reshaping competition and spurring innovation amid economic optimism and shifting antitrust dynamics

EU penalties and a US trial highlight growing pressure on Big Tech acquisitions and market practices.

Retailers prepare for looser antitrust scrutiny under Trump: The environment is likely to be more favorable for blockbuster mergers like the Kroger-Albertsons deal.

The US ad industry is at a crossroads. Which path it takes will depend heavily on which candidate is elected.

They argue that “click to cancel” is costly and unnecessary, setting up a showdown over consumer protections and industry compliance.

Streamers, pay TV sue to block click-to-cancel: The FTC’s attempt to standardize digital cancellations may have an uphill battle.

The blocked Tapestry-Capri merger is a major victory for Lina Khan and the FTC: Whether it can build on that momentum depends in part on who wins the presidential election.